11/25/2020 7:35:54 AM
Kantaro Receives FDA Emergency Use Authorization For COVID-SeroKlir
11/5/2020 6:33:29 AM
Bio-Techne Declares Dividend Of $0.32, Payable Nov. 27, Record Nov. 16
11/5/2020 6:32:12 AM
Bio-Techne Q1 GAAP EPS $0.83 Vs $0.37 Year Ago
10/26/2020 7:47:06 AM
Kantaro Gets CE Marking For COVID-SeroKlir And COVID-SeroIndex, Kantaro's Quantitative SARS-CoV-2 IgG Antibody Test Kits
10/19/2020 7:03:39 AM
Bio-Techne Announces Commercial Release Of SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western
10/1/2020 7:06:32 AM
Bio-Techne Announces Opening Of Its New Canadian Office In Toronto
9/30/2020 7:03:29 AM
Bio-Techne Unveils Opening Of Its GMP Manufacturing Facility In St. Paul, MN
9/23/2020 7:11:33 AM
Bio-Techne Announces Publication Of ExoDx Prostate Test Study In Patients With Prior Negative Prostate Biopsy
9/21/2020 7:03:17 AM
Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The R&D Systems Product Portfolio
9/17/2020 7:03:13 AM
Bio-Techne And QIAGEN Announce Expansion And Extension Of Non-exclusive Partnership
9/8/2020 7:04:26 AM
Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership
8/19/2020 8:08:24 AM
Bio-Techne In Partnership With Leica Biosystems Announce The Automation Of RNAscope COVID-19 Probes On BOND RX